SCHEMBL25807

SCHEMBL25807

CC(C)C(Cl)OC(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25365898 1.00
SCHEMBL29101104 0.82 ALDH1A1 (0.43)
SCHEMBL3359533 0.80 TSHR (0.35)
SCHEMBL1171077 0.78
SCHEMBL2101489 0.78
SCHEMBL7403671 0.78
SCHEMBL25559 0.77
SCHEMBL3024 0.77
SCHEMBL20017949 0.77
SCHEMBL8990506 0.76 SMN1; SMN2 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 324 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122070276-A Prodrugs of xanomeline, prodrugs of trospium chloride and methods of using the same 人类生物科学股份有限公司 2026-05-19 CN disclosed
US-20260078098-A1 PROCESS OF MAKING DERIVATIVES OF SUBSTITUTED MORPHOLINES SUPERNUS PHARMACEUTICALS, INC. (US) 2026-03-19 US disclosed
EP-4705289-A1 PRODRUGS OF XANOMELINE, PRODRUGS OF TROSPIUM AND METHODS OF USE THEREOF Terran Biosciences Inc. (US) 2026-03-11 EP disclosed
EP-4687909-A2 DERIVATIVES OF SUBSTITUTED MORPHOLINES AND USES THEREOF Supernus Pharmaceuticals, Inc. (US) 2026-02-11 EP disclosed
EP-4681777-A2 PRODRUGS OF KETAMINE, COMPOSITIONS AND USES THEREOF XWPharma Ltd. (KY) 2026-01-21 EP disclosed
EP-3737665-B1 PRODRUGS OF KETAMINE, COMPOSITIONS AND USES THEREOF XWPHARMA LTD (KY) 2026-01-07 EP disclosed
US-12516023-B2 NMDA antagonist prodrugs ASTRAZENECA AB (SE) 2026-01-06 US disclosed
EP-4594319-A1 BICYCLIC COMPOUNDS Aligos Therapeutics, Inc. (US) 2025-08-06 EP disclosed
US-20250206724-A1 SUBSTITUTED 3-AMINO INDAZOLE DERIVATIVES AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2025-06-26 US disclosed
US-20250122180-A1 DERIVATIVES OF SUBSTITUTED MORPHOLINES AND USES THEREOF SUPERNUS PHARMACEUTICALS, INC. (US) 2025-04-17 US disclosed
US-5587374-A BACTERICIDES TREATING INFECTIONS GLAXO SPA (IT) 1996-12-24 US disclosed
CN-1030917-C Heterocyclic compounds GLAXO SPA (IT) 1996-02-07 CN disclosed
EP-0495953-B1 10-(1-Hydroxyethyl)-11-oxo-1-azatricyclo[7.2.0.0(3,8)]undec-2-ene-2-carboxylic acid esters and a process for preparing thereof GLAXO SPA (IT) 1994-06-08 EP disclosed
EP-0495953-A1 10-(1-Hydoxyethyl)-11-oxo-1-azatricyclo(7.2.0.0(3,8)undec-2-ene-2-carboxylic acid esters and a process for preparing thereof. GLAXO SPA (IT) 1992-07-29 EP disclosed
US-5120841-A Antibiotics for easy absorption TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-06-09 US disclosed
CN-1060094-A Heterogeneous ring compound GLAXO SPA (IT) 1992-04-08 CN disclosed
WO-1992003437-A1 10(1-HYDROXYETHYL)-11-OXO-1-AZATRICYCLO[7.2.0.0.3.8]UNDEC-2-ENE-2-CARBOXYLIC ACID ESTERS AND A PROCESS FOR PREPARING THEREOF GLAXO S.P.A. (IT) 1992-03-05 WO disclosed
EP-0128029-B1 CEPHALOSPORIN ESTER DERIVATIVES, THEIR PRODUCTION AND USE Takeda Chemical Industries, Ltd. (JP) 1989-02-08 EP disclosed
US-4772695-A DEHYDROHALOGENATION, INSECTICIDES SOCIETE NATIONALE DES POUDRES ET EXPLOSIFS (FR) 1988-09-20 US disclosed
EP-0128029-A2 Cephalosporin ester derivatives, their production and use Takeda Chemical Industries, Ltd. (JP) 1984-12-12 EP disclosed